UBC has focused on drug safety evaluation with RWD for more than 15 years and is aligned with FDA’s Sentinel Initiative.
UBC’s safety scientists and epidemiologists provide comprehensive and customized RWD solutions to evaluate the safety of your marketed products.
- Global Database Feasibility Studies
- Protocol Development -Designing Post-Marketing Safety Studies
- Study Implementation
- RWD automated software for signal identification and refinement